Pharmacokinetic Characteristics
- Terminal elimination half-life: 5.4 hours
- Protein binding: 98% (mainly albumin)
- Steady state reached within 3 - 5 days
- Age, gender, race, body weight and renal function appear not to have a relevant effect on PK properties